CASI Pharmaceuticals Reports $9.8M Sales Revenue For Q2, Up 15% Y/Y And 18% Q/Q
Portfolio Pulse from Benzinga Newsdesk
CASI Pharmaceuticals has reported a sales revenue of $9.8 million for Q2, marking a 15% increase year-over-year and an 18% increase quarter-over-quarter.
August 11, 2023 | 11:06 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CASI Pharmaceuticals' Q2 sales revenue has increased by 15% Y/Y and 18% Q/Q to $9.8 million.
CASI Pharmaceuticals' reported increase in sales revenue for Q2 indicates a positive financial performance. This could potentially lead to an increase in investor confidence and a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100